Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

PLEXXIKON INC., Case No. 4:17-cv-04405-HSG

8 Plaintiff, ORDER GRANTING PLEXXIKON vs. INC.’S MOTION FOR SUMMARY

JUDGMENT OF NO ANTICIPATION

NOVARTIS PHARMACEUTICALS Re: Dkt. No. 167

CORPORATION,

11 Defendant.

Pending before the Court is Plaintiff Plexxikon Inc.’s motion for summary judgment that the asserted claims of U.S. Patent Nos. 9,469,640 (the “’640 Patent”) and 9,844,539 (the “’539 Patent”) are not anticipated under 35 U.S.C. § 102 by U.S. Patent No. 4,595,780 (“Shionogi”) and PCT Patent Publication No. WO 06/124874 (the “Kalypsys Application”). Dkt. No. 167. The Court heard argument on the motion, Dkt. No. 341, and GRANTS it for the reasons detailed below. I. BACKGROUND Plexxikon Inc. (“Plexxikon”) accuses Defendant Novartis Pharmaceutical Corporation (“Novartis”) of infringing claims 1, 2, 4-6, 9, and 11-12 of the ’640 Patent and claims 1, 2, 4-9, 11-12, and 14-19 of the ’539 Patent. Novartis responds, inter alia, that…